跳到主要內容區塊
:::首頁 > 就醫指南 > 醫師專長介紹

蔡易臻醫師

引用
現在日期 2024/09/20
科別分類符號 醫師個人簡介
主治專長
乳房外科、乳房疾病、乳房腫瘤手術、乳癌相關診斷及治療
專業經驗
臺中榮民總醫院 乳房腫瘤外科
重要經歷/進修訓練
現任:臺中榮民總醫院外科部 乳房腫瘤外科主治醫師
臺北榮民總醫院外科部一般外科住院醫師
臺北榮民總醫院外科部一般外科總醫師
高雄榮民總醫院屏東分院外科部主治醫師
學歷
國立臺灣大學醫學系畢業
現讀 中國醫藥大學生物醫學研究所博士班
專科證照
衛生署醫師執照
衛生署外科專科醫師
台灣消化系外科醫學會專科醫師
台灣內視鏡外科專科醫師
台灣乳房專科醫師
代表作
1. Preliminary outcomes of accelerated partial breast irradiation by interstitial multicatheter brachytherapy with intraoperative free-hand catheter implantation in early breast cancer.
Cheng HS, Hung CC, Wang KC, Tsai IC, Lin JF, Yeh HL.
J Chin Med Assoc. 2023 Feb 28:e000893. doi: 10.1097/JCMA.0000000000000893. Online ahead of print.
2. Comparison of overall survival after neoadjuvant and adjuvant chemotherapy in patients with early breast cancer with immediate breast reconstruction after mastectomy: A retrospective, matched case-control study.
Liu CH, Yang JR, Tsai IC, Hsu CY, Yean LC, Hung CC.
Oncol Lett. 2022 Oct 21;24(6):437. doi: 10.3892/ol.2022.13557. eCollection 2022 Dec.
3. Analysis of EZH2 Genetic Variants on Triple-Negative Breast Cancer Susceptibility and Pathology.
Liu LC, Chien YC, Wu GW, Hua CH, Tsai IC, Hung CC, Wu TK, Pan YR, Yang SF, Yu YL.
Int J Med Sci. 2022 May 29;19(6):1023-1028. doi: 10.7150/ijms.71931. eCollection 2022.
4. Clinical Outcomes of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 Breast Cancer Patients: A Single-Center Retrospective Study.
Hung CC, Tsai IC, Hsu CY, Lin HC.
J Clin Med. 2022 Mar 5;11(5):1434. doi: 10.3390/jcm11051434.
5. Capsanthin induces G1/S phase arrest, erlotinib-sensitivity and inhibits tumor progression by suppressing EZH2-mediated epigenetically silencing of p21 in triple-negative breast cancer cells.
Wu JY, Chien YC, Tsai IC, Hung CC, Huang WC, Liu LC, Yu YL.
Aging (Albany NY). 2021 May 2;13(9):12514-12525. doi: 10.18632/aging.202925. Epub 2021 May 2.
6. Efficacy Of Pegylated Liposomal Doxorubicin-based Neoadjuvant Chemotherapy In Breast Cancer: A Single Center Experience.
Tsai IC, Hung CC.
Clin Invest Med. 2021 Mar 21;44(1):E7-14.
7. The Efficacy of Pegylated Liposomal Doxorubicin-Based Neoadjuvant Chemotherapy in Breast Cancer: A Retrospective Case-Control Study in Taiwan.
Hung CC, Yang Y, Tsai IC, Hsu CY, Liu CH, Yang JR.
Biochem Res Int. 2020 Apr 28;2020:5729389. doi: 10.1155/2020/5729389. eCollection 2020.
8. Breast adenosquamous cell carcinoma presented in an intracystic form.
Liu Y, Hung CC, Chen YA, Tsai IC.
Asian J Surg. 2019 Jun;42(6):711-714. doi: 10.1016/j.asjsur.2019.02.005. Epub 2019 Mar 11.
回頂端